Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis

  • STATUS
    Recruiting
  • End date
    Dec 5, 2026
  • participants needed
    40
  • sponsor
    Indiana University
Updated on 19 February 2024
cirrhosis
ketogenic diet
fatty liver

Summary

This is an open-label, randomized study comparing a monitored ketogenic diet intervention using standard ketogenic diet (SKD) and standard of care (SOC) dietary recommendations for 16 weeks. Subjects enrolled in the standard of care group will receive a voucher to Weight Watchers after study completion.

Description

The primary aim is to assess the safety of ketogenic diet as compared to standard of care approach for weight loss in patients with compensated cirrhosis due to NASH. The safety endpoints captured in the study include liver decompensation events, measured through several questionnaires, fasting blood glucose, serum creatinine, fasting lipid profile and other adverse events. The tolerability of the ketogenic diet will be assessed by study compliance and by administering a questionnaire.

Secondary aims include weight loss, changes in body composition via serial use of bioelectrical impedance via an Inbody Machine, changes in liver fat and liver stiffness using MRI and proton density fat fraction (MRI-PDFF), liver biochemistries, changes in Child-Turcotte-Pugh and MELD scores measured via labs and changes in liver steatosis and stiffness via serial measures of VCTE by FibroScan.

Details
Condition Cirrhosis, NASH - Nonalcoholic Steatohepatitis
Age 18-100 years
Treatment Dietary consult for participants in the ketogenic diet arm, Dietary consult for participants in the standard of care arm
Clinical Study IdentifierNCT04383951
SponsorIndiana University
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

NASH cirrhosis (criteria in Appendix 1) with obesity (BMI >30 kg/m2)
Age 18 and greater

Exclusion Criteria

Actively participation in investigational drug treatment for non-alcoholic fatty liver disease
Currently taking medications for weight loss or have joined a supervised weight loss program prior to enrollment
Have hepatocellular carcinoma and are undergoing therapy
Women who become pregnant or plan to become pregnant prior to the study date; female subjects who become pregnant during the study will be withdrawn from the study
Pacemaker or implantable cardioverter devices
History of hepatic surgery
Current significant alcohol consumption, defined as more than 20 grams per day in females or 30 grams per day in males
Presence of ascites or hepatic encephalopathy
Symptomatic gastroparesis
Uncontrolled diabetes, as defined by a HgbA1C >11%
Uncontrolled congestive heart failure
Active infections
Child Turcotte Pugh score > 6
MELD score >12
Unwilling to undergo an MRI or have contraindications to an MRI
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.